Digital Biomarkers

By: Bank of Baroda
Wed Dec 9, 2020
Share This:

The surge in usage and attractiveness of connected digital devices and health-related mobile apps has created an innovative set of huge, varied and complex data sets known as “digital biomarkers.” These are defined as objective, reckonable, physiological and behavioural measures that are collected by sensors embedded in portable, wearable, implantable or digestible devices


According to the market intelligence study published by BIS Research titled Global Digital Biomarkers Market - Analysis and Forecast, 2019-2025, the digital biomarker market generated revenue of $524.6 million in 2018 and is estimated to grow over $5.64 billion by the end of 2025.

Innovative healthcare startups ushering in this new era in healthcare have a fundamental understanding of both the technical aspects of life sciences and emerging technologies. For instance, FeetMe has created smart inner insoles that provide gait analysis in real time. Some diabetic patients lose sensitivity and have ulcers that can lead to amputations. FeetMe insoles can help to monitor pressure to avoid ulcers.

Mindstrong Health is a healthcare company dedicated to transforming brain health through measurement science. By measuring brain function passively and continuously through individuals' interactions with smartphones, Mindstrong's platform helps individuals and health care providers detect brain health deterioration early and deliver pre-emptive care.

Machine Medicine provides objective mobility metrics from video using extensive medical knowledge and state-of-the-art artificial intelligence. The system is able to track activities, walking patterns, detect falls and early signs of disease and alert health professionals when an intervention is needed.

There are roughly 300 biomarkers that can be detected in human breath. Breathometer has created a portable breath analysis platform by leveraging smartphones that are carried by every consumer. With a Breathometer and the mobile app, it enables convenient, non-invasive and cost effective detection and monitoring of several types of application ranging from alcohol, oral healthcare, hydration, fat burning, asthma, diabetes and even lung cancer.

In case of the current pandemic, Innovators and biopharmaceutical companies are looking at data from physiological sensors that offer RPM solutions for patients infected with Covid-19. Utilising data from these wearable sensors provides a measure of symptoms and identification of real-time digital biomarkers which are identified and reported through analytics, often powered by AI. Another important use case of digital bio markers includes pharmaceutical drug development by cheaply and efficiently allowing more people throughout the world to contribute their health data to virtual clinical trials. We truly believe that this new healthcare model would democratize, expedite and improve availability of cost effective healthcare for the masses.

Leave a Comment

Search in Archives

Back to Top